ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Induction therapy"

  • 2021 American Transplant Congress

    Modification in Immunosuppression Regimens to Safely Perform Kidney Transplants Amid the Covid-19 Pandemic

    L. Von Stein, O. Witkowsky, L. Samidurai, K. Flores, M. Doraiswamy, T. Pesavento, P. Singh

    The Ohio State University Wexner Medical Center, Columbus, OH

    *Purpose: In the USA, there was a 51.1% reduction in kidney transplant (KTx) since March 2020 due to concerns for contraction of COVID-19 in transplant…
  • 2021 American Transplant Congress

    Covid-19 Severity within One Year of Liver, Pancreas and Kidney Transplantation

    H. Sarumi, J. Fisher, B. Johnson, T. Pruett

    Solid Organ Transplant Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: The current pandemic has created uncertainty in the severity of COVID-19 in transplant recipients, especially those given lymphocyte depleting therapy within a year prior…
  • 2021 American Transplant Congress

    Influence of Induction Therapy and Antiretroviral Regimen on Outcomes in HIV Positive Renal Transplant Recipients

    C. Rogers Marks1, C. Durand2, J. Hand3, M. Abidi4, M. Malinis5, B. Barnaba2, H. Patel6, C. D. Alonso6

    1Massachussetts General Hospital, Boston, MA, 2Johns Hopkins Medical Center, Baltimore, MD, 3Ochsner Medical Center, New Orleans, LA, 4Univ. of Colorado, Aurora, CO, 5Yale, New Haven, CT, 6Beth Israel Deaconess Medical Center, Boston, MA

    *Purpose: Transplantation of HIV+ individuals has become more common over the past decade with increasing data supporting good outcomes. Questions remain regarding the impact of…
  • 2021 American Transplant Congress

    Basiliximab versus Alemtuzumab: The Association Between Induction Agent and Airway Complications Following Lung Transplantation

    M. Furukawa1, E. G. Chan1, T. Harano1, J. Ryan1, R. Rivosecchi2, M. R. Morrell1, P. G. Sanchez1

    1Cardiothoracic Surgery, UPMC, Pittsburgh, PA, 2PUH-Pharmacy, UPMC, Pittsburgh, PA

    *Purpose: Controversy still exist regarding the best induction strategy for lung transplantation. At our institution, induction is defined based on donor recipient CMV match. While…
  • 2021 American Transplant Congress

    Single-Dose Basiliximab Induction Therapy in Low-Immunologic Risk Kidney Transplant Recipients

    A. Hutchins, J. Schoen, J. S. McMullen

    Pharmacy, Nebraska Medicine, Omaha, NE

    *Purpose: The purpose of this study is to examine the outcomes associated with single-dose basiliximab in low-immunologic risk kidney transplant recipients following a revision to…
  • 2021 American Transplant Congress

    Primary Graft Dysfunction in a Risk-Stratified vs. Routine Induction Protocol in Heart Transplant Recipients

    J. S. van Zyl1, H. Zafar1, P. M. Nguyen2, J. Felius1, T. Sam3, S. A. Hall3

    1Baylor Scott & White Research Institute, Dallas, TX, 2Texas A&M University College of Medicine Health Science Center, Dallas, TX, 3Baylor Scott & White Health, Dallas, TX

    *Purpose: Treatment of left ventricular primary graft dysfunction (PGD-LV) is supportive in nature. We aim to evaluate whether a change in induction protocol from a…
  • 2021 American Transplant Congress

    Impact of Induction Immunosuppression Selection on Clinical Outcomes in Kidney Transplant Recipients During the COVID-19 Pandemic in New York City

    K. Khalil, S. Jonchhe, J. Stern, T. C. Lewis, N. Alnazari, B. Lonze, Z. Stewart Lewis, N. Ali

    Transplant Institute, NYU Langone Health, New York, NY

    *Purpose: As an early epicenter in the coronavirus pandemic, our center modified induction immunosuppression strategies for transplantation. We sought to determine if changes in induction…
  • 2021 American Transplant Congress

    Cost Savings Initiative with Idea Body Weight Dosing of Rabbit Anti-thymocyte Globulin (rATG) Induction in an Older Kidney Transplant Population: A Single Center Analysis

    C. LaFratte1, S. Witek1, D. Sawinski2, J. Trofe-Clark2, C. Sammons2, B. Hardek1, R. Samudralwar1, A. Forte1, S. Lyle1, J. Rashid1, G. Malat2

    1Pharmacy, Hospital of Univ of Pennsylvania, Philadelphia, PA, 2Penn Transplant Institute, Hospital of Univ of Pennsylvania, Philadelphia, PA

    *Purpose: Optimal dosing schemes for rATG induction are not well defined for older kidney transplant recipients (KTRs), who are at greater risk for adverse events…
  • 2021 American Transplant Congress

    The Impact of Fixed-Dose Alemtuzumab in Renal Transplant Recipients According to Weight

    S. Mandala1, N. Khodieva2, A. Bigness1, S. Mohamed2, H. Mohammed1, K. Robichaux2, A. Brueckner3, R. Baliga4, J. Buggs5, A. Kumar1, L. Bowman3

    1Morsani College of Medicine, University of South Florida, Tampa, FL, 2Honors College, University of South Florida, Tampa, FL, 3Transplant Pharmacy, Tampa General Hospital, Tampa, FL, 4Nephrology, Florida Kidney Physicians, Tampa, FL, 5Transplant Surgery, Tampa General Hospital, Tampa, FL

    *Purpose: Alemtuzumab, a potent anti-CD52 monoclonal antibody is used for induction immunosuppression post-renal transplantation as a fixed 30mg dose regardless of the patient’s weight. The…
  • 2020 American Transplant Congress

    Maintenance Steroids in the Setting of Alemtuzumab Induction Post-Kidney Transplant Increases Risk of Infection and Hospital Readmission

    A. R. Webb, A. A. Al-Bahou, A. J. Brueckner, A. T. Logan, R. S. Baliga, L. J. Bowman Anger

    Tampa General Hospital, Tampa, FL

    *Purpose: This study sought to assess the safety of steroid-containing maintenance immunosuppression in the setting of alemtuzumab (ALEM) induction.*Methods: Adult (>18 years) kidney transplant recipients…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 31
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences